Cite
MLA Citation
Srinivas K. Tantravahi et al.. “A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia.” Leukemia & lymphoma, vol. 57, no. 10, n.d., pp. 2441–2444. http://access.bl.uk/ark:/81055/vdc_100034959453.0x000031